Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

Graziella Filippini, Marinella Clerico, Omid Beiki, Miriam Mattoscio, Federico Piazza, Cinzia Del Giovane, Sten Fredrikson, Irene Tramacere, Antonio Scalfari

Research output: Contribution to journalArticle

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To estimate the benefit and safety of all DMDs that have been evaluated in all studies (randomised and non-randomised) for early treatment. We will employ novel, high-quality methods for systematic reviews and network meta-analysis in collaboration with the Cochrane Multiple Interventions Group. To evaluate the quality of the evidence provided by existing studies. We will consider the credibility of included studies and other characteristics of the evidence base as we characterise conclusions pertaining to high, low or very low quality of evidence. We will undertake this review in accordance with the methods described by the template protocol published online and will use this template as we prepare the review.

Original languageEnglish
Article numberCD012200
JournalThe Cochrane database of systematic reviews
Volume2016
Issue number5
DOIs
Publication statusPublished - May 19 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this

    Filippini, G., Clerico, M., Beiki, O., Mattoscio, M., Piazza, F., Del Giovane, C., Fredrikson, S., Tramacere, I., & Scalfari, A. (2016). Treatment with disease modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. The Cochrane database of systematic reviews, 2016(5), [CD012200]. https://doi.org/10.1002/14651858.CD012200